Delivery Order SPE2DB22D2103-SPE2DB24FR9YP

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order, valued at $2,566.45, is for the supply of 4565943855 SHINGRIX VIAL KITS. The order is a firm fixed-price contract with an ultimate completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medical products and prescription drugs to various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $4,187.16. The contract is for the supply of SHINGRIX vial kits, which are likely vaccines or other medical products. The order has a firm fixed price and a completion date of September 18, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.18, is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.18, is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through May 12, 2025. The contract is not set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,165,319 units of the SHINGRIX vaccine vial kit, with a ceiling value of $2,213.75. The delivery order is a firm-fixed price contract type with a period of performance through July 17, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medical...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) to provide SHINGRIX vaccine vial kits. The order has a ceiling value of $6,966.20 and a completion date of June 13, 2025. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies to support military and other...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vaccine vial kits. The delivery order, valued at $10,956.92, has a firm fixed-price contract type and an ultimate completion date of August 14, 2024. AmerisourceBergen, the prime contractor, will provide these critical medical supplies to support the healthcare needs of military treatment facilities and other federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,567,926,143 units of SHINGRIX VIAL KITS, with a ceiling value of $64,050.58. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a ceiling value of $6,372.14 and a period of performance through April 11, 2025. The contract is designated as a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $8,832.64 fixed-price contract is for the supply of SHINGRIX vial kits, a vaccine product. The order has a completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9YP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565815778 SHINGRIX VIAL KITS. The firm-fixed-price delivery order is valued at $21,650.14 and has a period of performance through September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. This IDC enables DLA to efficiently procure a wide range of medical commodities, including prescription drugs and vaccines, to support military treatment facilities and other federal healthcare providers.

Generated 12/16/24, 2:06 PM